Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.773
-0.130 (-4.48%)
At close: May 30, 2025, 4:00 PM
2.770
-0.003 (-0.11%)
After-hours: May 30, 2025, 6:38 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $38.04 million as of May 30, 2025. Its market cap has increased by 45.06% in one year.
Market Cap
38.04M
Enterprise Value
26.99M
1-Year Change
45.06%
Ranking
Category
Stock Price
2.77
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $38.04M, a decrease of -56.38%. That is a compound annual growth rate of -5.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 648.68B |
| Johnson & Johnson | 369.52B |
| AbbVie | 327.88B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.48B |
| Abbott Laboratories | 231.14B |
| Novartis AG | 219.70B |
| AstraZeneca | 217.50B |